Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03801525
Title Study to Assess the Efficacy and Safety of Ublituximab Plus Umbralisib in Combination With Venetoclax in Subjects With CLL (ULTRA-V)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors TG Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
TG Therapeutics Investigational Trial Site Birmingham Alabama 35294 United States Details
TG Therapeutics Investigational Trial Site Huntsville Alabama 35805 United States Details
TG Therapeutics Investigational Trial Site Tucson Arizona 85711 United States Details
TG Therapeutics Investigational Trial Site Duarte California 91010 United States Details
TG Therapeutics Investigational Trial Site La Jolla California 92093 United States Details
TG Therapeutics Investigational Trial Site Aurora Colorado 80012 United States Details
TG Therapeutics Investigational Trial Site Stamford Connecticut 06904 United States Details
TG Therapeutics Investigational Trial Site Boca Raton Florida 33486 United States Details
TG Therapeutics Investigational Trial Site Fort Myers Florida 33901 United States Details
TG Therapeutics Investigational Trial Site Jacksonville Florida 32224 United States Details
TG Therapeutics Investigational Trial Site Saint Petersburg Florida 33705 United States Details
TG Therapeutics Investigational Trial Site Tampa Florida 33612 United States Details
TG Therapeutics Investigational Trial Site Atlanta Georgia 30322 United States Details
TG Therapeutics Investigational Trial Site Decatur Illinois 62526 United States Details
TG Therapeutics Investigational Trial Site Niles Illinois 60714 United States Details
TG Therapeutics Investigational Site Peoria Illinois 61615 United States Details
TG Therapeutics Investigational Trial Site Fort Wayne Indiana 46804 United States Details
TG Therapeutics Investigational Trial Site Indianapolis Indiana 46237 United States Details
TG Therapeutics Investigational Trial Site Des Moines Iowa 50309 United States Details
TG Therapeutics Investigational Trial Site Westwood Kansas 66210 United States Details
TG Therapeutics Investigational Site Louisville Kentucky 40207 United States Details
TG Therapeutics Investigational Trial Site Bethesda Maryland 37210 United States Details
TG Therapeutics Investigational Trial Site Columbia Maryland 21044 United States Details
TG Therapeutics Investigational Trial Site Ann Arbor Michigan 48197 United States Details
TG Therapeutics Investigational Trial Site Detroit Michigan 48201 United States Details
TG Therapeutics Investigational Trial Site Detroit Michigan 48202 United States Details
TG Therapeutics Investigational Trial Site Rochester Minnesota 55905 United States Details
TG Therapeutics Investigational Trial Site Omaha Nebraska 68198 United States Details
TG Therapeutics Investigational Trial Site Lebanon New Hampshire 03756 United States Details
TG Therapeutics Investigational Trial Site Hackensack New Jersey 07601 United States Details
TG Therapeutics Investigational Trial Site Morristown New Jersey 07960 United States Details
TG Therapeutics Investigational Trial Site New York New York 10065 United States Details
TG Therapeutics Investigational Trial Site Charlotte North Carolina 28204 United States Details
TG Therapeutics Investigational Trial Site Columbus Ohio 43210 United States Details
TG Therapeutics Investigational Trial Site Eugene Oregon 97401 United States Details
TG Therapeutics Investigational Trial Site Philadelphia Pennsylvania 19106 United States Details
TG Therapeutics Investigational Trial Site Charleston South Carolina 29414 United States Details
TG Therapeutics Investigational Trial Site Greenville South Carolina 29616 United States Details
TG Therapeutics Investigational Trial Site Chattanooga Tennessee 37404 United States Details
TG Therapeutics Investigational Trial Site Knoxville Tennessee 37916 United States Details
TG Therapeutics Investigational Trial Site Nashville Tennessee 37203 United States Details
TG Therapeutics Investigational Trial Site Austin Texas 78705 United States Details
TG Therapeutics Investigational Trial Site San Antonio Texas 78229 United States Details
TG Therapeutics Investigational Trial Site Tyler Texas 75702 United States Details
TG Therapeutics Investigational Trial Site Ogden Utah 84405 United States Details
TG Therapeutics Investigational Trial Site Salt Lake City Utah 84106 United States Details
TG Therapeutics Investigational Trial Site Blacksburg Virginia 24060 United States Details
TG Therapeutics Investigational Trial Site Gainesville Virginia 20155 United States Details
TG Therapeutics Investigational Trial Site Seattle Washington 98104 United States Details
TG Therapeutics Investigational Trial Site Seattle Washington 98108 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field